Presentation is loading. Please wait.

Presentation is loading. Please wait.

Contemporary Considerations in Biomarker-Guided Therapy

Similar presentations


Presentation on theme: "Contemporary Considerations in Biomarker-Guided Therapy"— Presentation transcript:

1 Contemporary Considerations in Biomarker-Guided Therapy

2

3 Program Goals

4 Natriuretic Peptides

5 Patient Case 83-year-old Woman With Increasing Dyspnea, Weight Gain (2kg), and Leg Edema

6 Patient Case (cont)

7 Patient Case (cont)

8 Patient Case (cont)

9 Patient Case (cont)

10

11 BASEL and IMPROVE-CHF

12

13

14 Guided Therapy Meta-Analyses Mortality

15

16 Therapies That Affect B-Type Natriuretic Peptide Levels

17

18

19 Serial ST2 Measurements in AHF

20 Role of Troponins in Acute HF

21 Patient Case 57-year-old Man With Severe Dyspnea

22 Patient Case (cont)

23 Patient Case (cont)

24 Patient Case (cont)

25 Patient Case (cont)

26 Abbreviations

27 References

28 References (cont)


Download ppt "Contemporary Considerations in Biomarker-Guided Therapy"

Similar presentations


Ads by Google